You end your post by asking why don't I think that Afinitor is being tested in a single agent sarcoma phase 3 trial. You answer the question yourself in your opening remark.
Rather than going back and forth with our opposing views on the prospects of Rida meeting it's endpoints in the succeed trial, I suggest that we wait just a couple of weeks or so to get the definitive answer to that question. Then when the results come out, I will accept your appology :O)
News 
Market Data 
Discover 
AI
